Intellectual Property India Publishes Patent Application for Pharmaceutical Compositions Comprising Ox40 Targeting Antibodies And Uses Thereof

MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202647114834 A) filed by Insight Merger Sub Ii on September 25, 2026, for Pharmaceutical Compositions Comprising Ox40 Targeting Antibodies And Uses Thereof.

Inventors include Sun, Qiang; Jin, Xionghua; Xu, Zhihao; and Fan, Pengcheng.

The application for the patent was published on October 02, 2026, under issue no. 40/2026.

Abstract: Provided herein are pharmaceutical compositions, formulations and dosage forms containing high concentrations of monoclonal anti-OX40 antibodies. Methods of using these pharmaceutical compositions, formulations and dosage forms, including, for example, treating OX40-associated diseases are also provided herein.

Disclaimer: Curated by HT Syndication.